Empery Asset Management, LP 13D and 13G filings for EyeGate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-20 4:40 pm Purchase | 2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG | Empery Asset Management, LP | 868,622 6.880% | 868,622 (New Position) | Filing |